MOTS-c Dosage Guide
Complete guide to MOTS-c dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
5 mg – 10 mg
Frequency
Once per week
Route
subcutaneous
Cycle Length
8–12 weeks
Reconstitution
Vial Size
10 mg
BAC Water
2.0 ml
Concentration
5,000 mcg/ml
Detailed Dosage Information
Research protocols typically use 5-10mg administered subcutaneously several times per week.
Optimal dosing not yet established.
Administration Method
Subcutaneous injection. Often combined with exercise protocols as it enhances exercise capacity and metabolic adaptation.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 5 mg/ml
Volume to inject: 1.500 ml
Syringe units: 150.0 units — exceeds 1 ml syringe, split into multiple injections
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with MOTS-c defaults. Adjust values as needed.
Side Effects to Monitor
Limited human data. Animal studies show good tolerability. May affect energy levels and exercise performance.
Safety Considerations & Risks
Research compound with limited human safety data. Long-term effects not characterized. May interact with metabolic medications.